Isolated Intraparotid Kaposi Sarcoma in Human Immunodeficiency Virus Type 1 Infection

Mayo Clinic Proceedings

Volumn 78, Issue 12, 2003, Pages 1561-1563

  Rizos, Evangelos ^a   Drosos, Alexandros A ^a   Ioannidis, John P A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; INDINAVIR; LAMIVUDINE; RNA; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CELL COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPH NODE; MALE; MEDICAL LITERATURE; PAROTID GLAND; VIRUS LOAD;

EID: 0344395634     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.12.1561     Document Type: Article

References (26)

1. Mongiardo FD, Tewfik TL. Kaposi's sarcoma of intra-parotid lymph nodes in AIDS. J Otolaryngol. 1991;20:243-246.
2. Zim S, Maceri D, Rice DH, Fedenko A. Quiz case 1: primary Kaposi sarcoma (KS) of an intraparotid lymph node. Arch Otolaryngol Head Neck Surg. 2000;126:1390, 1392.
3. Reath DB, Noone RB, Columbus M, Murphy JB. Primary Kaposi's sarcoma of an intraparotid lymph node with AIDS. Plast Reconstr Surg. 1987;80:615-618.
4. Mukherjee A, Silver CE, Rosario PG, Gerst PH. Kaposi's sarcoma of the parotid gland in acquired immunodeficiency syndrome. Am Surg. 1998;64:259-260.
5. Finfer MD, Schinella RA, Rothstein SG, Persky MS. Cystic parotid lesions in patients at risk for the acquired immunodeficiency syndrome. Arch Otolaryngol Head Neck Surg. 1988;114:1290-1294.
6. Castle JT, Thompson LD. Kaposi sarcoma of major salivary gland origin: a clinicopathologic series of six cases. Cancer. 2000;88:15-23
7. Atula T, Grenman R, Klemi P, Syrjanen S. Human papillomavirus, Epstein-Barr virus, human herpesvirus 8 and human cytomegalovirus involvement in salivary gland tumours. Oral Oncol. 1998;34:391-395.
8. Kessler E. Multicentric giant lymph node hyperplasia: a report of seven cases. Cancer. 1985;56:2446-2451.
9. Yeh CK, Fox PC, Fox CH, Travis WD, Lane HC, Baum BJ. Kaposi's sarcoma of the parotid gland in aquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol. 1989;67:308-312.
10. Bonzanini M, Togni R, Barabareschi M, Parenti A, Dalla Palma P. Primary Kaposi's sarcoma of intraparotid lymph node. Hístopa Histopathology. 1992;21:489-491.
11. Josephson J, Goldofsky E, Wenig BL. Primary Kaposi's of an intraparotid lymph node in a non-immunocompromised patient. Otolaryngol Head Neck Surg. 1988;99:341-343.
12. Shiboski CH, Hilton JF, Neuhaus JM, Canchola A, Greenspan D, University of California, San Francisco Oral AIDS Center Epidemiology Collaborative Group. Human immunodeficiency virus related oral manifestations and gender: a longitudinal analysis. Arch Intern Med. 1996;156:2249-2254.
13. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
14. Moore PS. The emergence of Kaposi's sarcoma-associated herpes-virus (human herpesvirus 8). N Engl J Med. 2000;343:1411-1413.
15. Wilkinson J, Cope A, Gill J, et al. Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. J Virol. 2002;76:2634-2640.
16. Greenspan D, Greenspan JS. HIV-related oral disease. Lancet. 1996;348:729-733.
17. Aboulafia DM. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy. Mayo Clin Proc. 1998;73:439-443.
18. Gill J, Bourboulia D, Wilkinson J, et al. Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma. J Acquir Immune Defic Syndr. 2002;31:384-390.
19. Tam HK, Zhang ZF, Jacobson LP, et al. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer. 2002;98:916-922.
20. DeSimone JA, Pomerantz RJ, Babinchak TJ. Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med. 2000;133:447-454.
21. Pellet C, Chevret S, Blum L, et al. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy [published correction appears in J Invest Dermatol. 2002;118:741]. J Invest Dermatol. 2001;117:858-863.
22. Pellet C, Chevret S, Blum L, et al. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy [published correction appears in J Invest Dermatol. 2002;118:741]. J Invest Dermatol. 2001;117:858-863.
23. Lukawska J, Cottrill C, Bower M. The changing role of radio-therapy in AIDS-related malignancies. Clin Oncol (R Coll Radiol). 2003;15:2-6.
24. Hengge UR, Ruzicka T, Tyring SK, et al. Update on Kaposi's sarcoma and other HHV8 associated diseases, part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis. 2002;2:281-292.
25. Hermans P. Kaposi's sarcoma in HIV-infected patients: treatment options. HIV Med. 2000;1:137-142.
26. Levine AM, Tulpule A. Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer. 2001;37:1288-1295.